| Application no. and date | 13774165.8 (espacenet) (Federated) (European Patent Register), 20131008 | | Patent/reg. no. and date | DK/EP 2906246, 20230726 | | Publication date | 20150819 | | Priority no. and date | EP 12188226, 20121011 | | EP pub. no. and date |
EP 2906246 20150819 | | Effective date | | | Applicant/owner | ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S, Tuborg Boulevard 12, 2900 Hellerup, DK | | Applicant ref. no. | V462621DK00 | | Inventor | BISEK, Nicola,
69120 Heidelberg, DE,
WEISBROD, Samuel,
69120 Heidelberg, DE,
STARK, Sebastian,
69120 Heidelberg, DE,
VOIGT, Tobias,
69120 Heidelberg, DE,
Rau, Harald,
69120 Heidelberg, DE,
KNAPPE, Thomas,
69120 Heidelberg, DE,
LAUFER, Burkhardt,
69120 Heidelberg, DE,
REIMANN, Romy,
69120 Heidelberg, DE,
SPROGÿE, Kennett, 2900 Hellerup, DK | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 47/60 (2017.01) , A61K 47/64 (2017.01) , A61K 47/69 (2017.01) , A61P 27/02 (2006.01) , A61P 3/10 (2006.01) , A61P 43/00 (2006.01) , A61P 9/00 (2006.01) , A61P 9/10 (2006.01) | | Title | VEGF-neutraliserende prodrugs omfattende ranibizumab til behandling af okulære tilstande, der er kendetegnet ved okulær neovaskularisering | | Int. application no. | EP2013070959 | | Int. publication no. | WO2014056923 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
